Raymond James Initiates Coverage On POINT Biopharma Global with Outperform Rating, Announces Price Target of $10
Raymond James analyst Rahul Sarugaser initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating and announces Price Target of $10.